Skip to main content

Topiramate

NDC 70518-2419 · REMEDYREPACK INC.

Generic nameTopiramate
Dosage formTABLET
RouteORAL
Active ingredient(s)TOPIRAMATE
Strength50 mg/1
Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

70518-2419-2 — 50 POUCH in 1 BOX (70518-2419-2) / 1 TABLET in 1 POUCH (70518-2419-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70518-0233 — topiramate, 70518-0625 — Topiramate, 70518-1180 — topiramate, 70518-1196 — Topiramate, 70518-1718 — topiramate, 70518-1937 — topiramate, 70518-1953 — topiramate, 70518-2001 — topiramate, 70518-2104 — topiramate, 70518-2391 — Topiramate, 70518-2517 — Topiramate, 70518-2955 — Topiramate, 70518-4247 — topiramate, 70518-4340 — Topiramate, 70518-4515 — topiramate, 70710-1039 — Topiramate, 70710-1040 — Topiramate, 70710-1041 — Topiramate, 70710-1042 — Topiramate, 70710-1043 — Topiramate, +289 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels